GSK3-Based PROTAC Proteolysis for Targeted Protein Degradation
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Existing technologies have limited reports on the enzyme properties of glycogen synthase kinase-3 (GSK3) beyond its kinase function, and there is a need for methods to utilize GSK3 as a protease for targeted proteolysis of proteins.
Innovation Solution
GSK3 is utilized as a protease, specifically through the use of GSK3-based proteolysis-targeting chimeras (PROTACs) formed by ligating target protein-binding and GSK3-binding ligands with a linker, leveraging its aspartate, serine, threonine, cysteine, and metalloprotease activities for efficient proteolysis.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Productivity
If GSK3 is used as a protease for targeted proteolysis, then the proteolysis efficiency and specificity are improved, but the knowledge gap regarding GSK3's enzyme properties beyond kinase function represents a limitation in existing technologies
Solution Approach 1:
The invention utilizes GSK3's inherent protease activity without requiring external modification or activation. By designing PROTAC molecules that recruit endogenous GSK3, the system leverages the cell's own proteolytic capability, achieving efficient targeted proteolysis while confirming GSK3's dual kinase-protease functionality
Solution Approach 2:
The PROTAC molecule serves as an intermediary that bridges the target protein and GSK3 protease. It contains a target-binding ligand, a GSK3-binding ligand, and a linker, facilitating the recruitment of GSK3 to the target protein complex to enable specific proteolysis
2Adaptability or versatility
If GSK3-based PROTACs are designed with multiple ligands and linkers, then the targeted proteolysis capability is improved, but the molecular complexity and design difficulty increase
Solution Approach 1:
The PROTAC molecule is segmented into distinct functional modules: a target-binding ligand portion, a GSK3-binding ligand portion, and a linker connecting them. This segmentation allows independent optimization of each module while maintaining overall functionality, simplifying the design process despite the complex overall structure
Solution Approach 2:
The invention employs universal building blocks for PROTAC design that can be applied across different target proteins. The GSK3-binding ligand and linker types can be reused and combined with different target-specific ligands, reducing design complexity through standardized components
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
GSK3-based PROTACs enable rapid and specific proteolysis of target proteins, overcoming limitations of existing proteolysis systems by directly utilizing GSK3's protease activity, offering broad applicability across eukaryotic organisms and potential for targeted degradation of harmful proteins.
Implementation Method 1
GSK3 is utilized as a protease, specifically through the use of GSK3-based proteolysis-targeting chimeras (PROTACs)... leveraging its aspartate, serine, threonine, cysteine, and metalloprotease activities for efficient proteolysis
Data Source
AI summary
Use of glycogen synthase kinase-3 (GSK3) as a protease, and a GSK3-based proteolysis-targeting chimera (PROTAC) and a preparation method and use thereof are provided, belonging to the technical field of proteolysis. The GSK3 and an N-terminal domain, an intermediate domain, or a C-terminal domain thereof have a protease activity and can achieve efficient proteolysis. Based on the GSK3 and other similar proteases, PROTACs can be developed to achieve efficient targeted proteolysis of a target protein.